— Know what they know.
Not Investment Advice
Also trades as: 6127.HK (HKSE) · $vol 26M

603127.SS SHH

Joinn Laboratories(China)Co.,Ltd.
1W: +6.9% 1M: +6.1% 3M: +24.4% YTD: +32.1% 1Y: +63.4% 3Y: +77.2% 5Y: -24.2%
¥49.30 ($7.35)
+4.48 (+10.00%)
 
SHH · Healthcare · Medical - Diagnostics & Research · Tech Score Buy · Power 60 · ¥36.9B mcap · 491M float · 8.19% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥36.9B ($5.5B)
52W Range26.25-55.68
Volume55,401,802
Avg Volume40,213,935
Beta0.83
Dividend¥0.12
Analyst Ratings
No analyst coverage
Company Info
CEODaniel Gao
Employees2,500
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2017-08-25
A5 Rongjing East Street
Beijing, BE 100176
CN
86 10 6786 9966
About Joinn Laboratories(China)Co.,Ltd.

Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms